Is Big Pharma Hinting At A SMID-Cap Biotech Rally?
February 03, 2016 at 13:16 PM EST
UBS analyst Andrew Peters believes investors may be missing a strong bullish sign in the biotech sector this earnings season. According ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.